Biotechs Warn: Pill Penalty, Policy Gaps, and Price Controls Threaten U.S. InnovationIncubate CoalitionMay 80 min readINC25_BioTech CEO Survey OnePager_v6.pdfDownload PDF • 2.59MB
Incubate Survey: Early-Stage Biotech CEOs Warn Medicare's Pill Penalty Is Driving Capital Out of the Sector
An Open Letter to Members of the 119th Congress and the Trump Administration from Leaders in the Life Sciences Community
Comentarios